COVID-19



Direct Communication Solutions, Inc.
Latest Comments
image_pdfimage_print

Revenue is forecast to triple, Valeo Pharma has 10 products in their portfolio

COVID-19 continues to be a huge global problem with global cases now over 112 million. Vaccines are a source of […]


Valeo Pharma’s Steve Saviuk on Hesperidin and reducing the risk of securing COVID-19

In a new InvestorIntel interview Tracy Weslosky speaks with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH | OTCQB: […]


StageZero on revenues being generated via testing operations, partners and a status report on the Aristotle test

In a recent InvestorIntel interview, Tracy Weslosky speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX: […]


Fever detection system sales driving Predictiv AI’s revenue higher

This week, Predictiv AI Inc. (TSXV: PAI) reported that its channel reseller in Quebec and Atlantic Canada, KleinCity Group, secured […]


Valeo Pharma’s approval and launch of immune support product line Redesca and Redesca HP anticipated to impact first half 2021 revenue

Most investors know that the pharmaceutical industry is a huge and mostly very profitable industry. What they may not know […]


Kozak on StageZero: Come for COVID, stay for the cancer testing

“15 years of work”, is how StageZero Life Sciences Ltd. (TSX: SZLS) Chairman and CEO James Howard-Tripp described why he […]


ZEN Graphene set to supply a viricidal coating for a minimum 100 million masks

This week ZEN Graphene Solutions Ltd. (TSXV: ZEN) (“ZEN”) and Trebor RX Corp. (“Trebor”) signed a Binding Letter of Intent […]